CD8A and breast carcinoma: In syngeneic mouse models of breast cancer, PI3K-γ inhibitor IPI-549 repolarized TAMs from M2 to M1, stimulated macrophage NF-κB expression, and reduced PD-L1 expression, thus promoting CD8 + T cell cytotoxicity (45).